GF
DGX icon

Genworth Financial’s Quest Diagnostics DGX Stock Holding History

Genworth Financial’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$1.86M Buy
+30,663
New +$1.83M 0.06% 191

Other funds holding DGX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
RI
Relational Investors San Diego, California $840M AUM 0.57% 1-Year Est. Return

Genworth Financial's DGX Position: Q2 2013 in Review

Genworth Financial opened a new position in Quest Diagnostics (DGX) in Q2 2013: 30,663 shares worth $1.86M. The stake represents 0.06% of the portfolio and ranks #191 among its holdings.

423 funds tracked by Wall St. Rank hold DGX as of Q2 2013.

  • Genworth Financial held 30,663 shares of Quest Diagnostics worth $1.86M as of Q2 2013.
  • Quest Diagnostics was a new Genworth Financial position in Q2 2013.
  • Quest Diagnostics made up 0.06% of Genworth Financial's portfolio in Q2 2013, its #191 holding.
  • 423 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2013.

Based on Genworth Financial's 13F filing for Q2 2013, filed 13 Aug 2013.